Search results for Gf Flow Symposium

Shaping the Future of Flow: GF Flow Symposium Connects Leaders Across the Built Environment 

The inaugural GF Flow Symposium on May 3-6, 2026, welcomed 700 attendees at the historic Gaylord Opryland Resort & Convention Center in Nashville, Tenn. Builders, developers, c...

Building North America’s Future: Industry Leaders to Unite at GF Flow Symposium

Scheduled for May 3-6, 2026, at the historic Gaylord Opryland Resort & Convention Center in Nashville, Tenn., the inaugural GF Flow Symposium will join builders, developers, co...

GLOBALFOUNDRIES Inc. (GFS) Presents at TD Cowen's 54th Annual Technology, Media & Telecom Conference Transcript

University of Rochester Medicine’s Flow Cytometry Resource Earns Prestigious Recognition from International Society for...

The Flow Cytometry Resource (FCR) at University of Rochester Medicine has garnered international acclaim by being selected among the 2026 cohort of Recognized Shared Resource Labor...

Gmppb Mutation Rescued by GSK3β Inhibition or Gene Therapy

In a groundbreaking study poised to redefine therapeutic strategies for muscular dystrophies, a team of researchers led by Fu, Wang, and Zhang have unveiled compelling evidence tha...

Peak Flow

Peak Flow

journal club

Garreta et al. (Nat Biomed Eng. Published online October 31, 2025. https://doi.org/10.1038/s41551-025-01542-1)

Abstract No. LBA20 Results from the GPX IDE Pivotal Clinical Trial (Evaluation of a Simple-Prep Controlled Embolic)

Distal embolization is desired for many embolic applications. In an IDE pivotal trial, a novel liquid embolic was used in both durable and pre-operative distal embolization procedu...

Flash glucose monitoring addition to self-monitoring of blood glucose and perinatal outcomes in gestational diabetes: a...

Self-monitoring of blood glucose represents the standard for glycemic monitoring in gestational diabetes mellitus, while the role of continuous glucose monitoring remains uncertain...

Flowserve Corporation 2026 Q1 - Results - Earnings Call Presentation

ACI’s 2nd Annual Summit on GLP-1 Law & Policy

The GLP-1 market is set to hit over $30 billion by 2030.  Intellectual property litigation and FDA crackdowns have led to a boom in M&A and partnership activity.  Long-term pat...

Consensus and controversies of international guidelines for the diagnosis, surveillance and management of fetal growth r...

To compare areas of consensus and disagreements across contemporary international and national guidelines on the diagnosis, surveillance, and management of fetal growth restriction...

G-Link CAR-T Delivery Platform Showcased at ASGCT

The modular plug-and-play protein adapter developed in collaboration with Menachem Rubenstein, PhD, of the Weizmann Institute allows drug developers to cap and retarget existing le...

AGBT 2026 Recap: NGS Big Bets and Spatial’s Rising Momentum

For the genomics community February means the season of big announcements as the AGBT meeting—which has earned a reputation for breaking field-shaping news—takes place. The meeting...

A three-dimensional shear dependent continuum model of platelet aggregation under flow

by David Montgomery, Eric S. Barrientos, Jake M. Grdadolnik, Kelli Henderickson, Aaron L. Fogelson, Keith B. Neeves, Karin Leiderman Platelet aggregation under flow is a key compo...

CME on Modern Therapies for Common Issues in Our Population held by Gauri Kaul Foundation

Srinagar, Apr 18: The Spring CME organised by Prof Upendra Kaul for the medical fraternity of the valley was attended by around 80 doctors. The eminent faculty included Prof A H Za...

Advances and Opportunities in Dual Chamber Injectables

In this panel discussion from the 2025 PODD: Partnership Opportunities in Drug Delivery Conference, pharma executives and drug delivery experts discuss progess in the development o...

SES Symposium 3.8. Programmable Morphing Matter: Bridging Bioinspiration, Mechanics, and Autonomous Design

CIMNE Summer school in Reduced-order and Data-driven models in Biomechanics miquel.aguirre Fri, 01/24/2025 - 05:35 Log in or register to post comments1691 views

FDA’s Megha Kaushal ASGCT talk: PFDD, patient voices, decision-making

I’ve been thinking more about the interplay between patient voices and FDA oversight of emerging cell and gene therapies. How do we find integration and balance here? In line with...

Abstract No. LBA3 ▪ FEATURED ABSTRACT The VENOS-2 Early Feasibility Study: Six-Month Outcomes of the Velocity® Percut...

Each of the two FDA-approved systems used to create percutaneous arteriovenous fistulas (pAVFs) for hemodialysis successfully and safely create vascular access. Unfortunately, many...

Impact of Continuous Glucose Monitoring on Clinical Outcomes and Productivity Losses Among People Living With Type 2 Dia...

That is the title of a new paper out yesterday in the Journal of Diabetes Science and Technology from my FTI colleague Marie Steele-Adjognon, along with Martha E. Shepherd, Jon Har...

ACI’s 2nd Annual Summit on GLP-1 Law & Policy

ACI’s 2nd Annual Summit on GLP-1 Law & Policy Anonymous (not verified) Mon, 04/20/2026 - 08:10 pharmagather item url ACI’s 2nd Annual Summit on GLP-1 L...

ASGCT CEO David Barrett Previews the Upcoming Conference in Boston

Before the conference gets underway, GEN spoke with David Barrett, JD, the CEO of ASGCT, to ask his perspective on what attendees should be looking out for, and what he, personally...

FGI Industries Ltd. 2025 Q4 - Results - Earnings Call Presentation